Next Article in Journal
The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
Next Article in Special Issue
Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders
Previous Article in Journal
Roles of the Endogenous Lunapark Protein during Flavivirus Replication
Previous Article in Special Issue
Is the First of the Two Born Saved? A Rare and Dramatic Case of Double Placental Damage from SARS-CoV-2
Comment published on 5 August 2021, see Viruses 2021, 13(8), 1545.
Article

SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland

1
Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland
2
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
3
Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH ‘s-Hertogenbosch, The Netherlands
4
Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0315 Oslo, Norway
5
Department of Child Health and Development, Norwegian Institute of Public Health, 0403 Oslo, Norway
6
Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland
7
Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland
8
Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland
9
School of Health Sciences (HESAV) Midwifery Department, University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland
*
Authors to whom correspondence should be addressed.
Similar contribution as senior authors.
Academic Editor: Luis Martinez-Sobrido
Viruses 2021, 13(7), 1199; https://doi.org/10.3390/v13071199
Received: 31 May 2021 / Revised: 15 June 2021 / Accepted: 18 June 2021 / Published: 22 June 2021
(This article belongs to the Special Issue Emerging Virus Infections in Adverse Pregnancy Outcomes)
As pregnant women are at high risk of severe SARS-CoV-2 infection and COVID-19 vaccines are available in Switzerland, this study aimed to assess the willingness of Swiss pregnant and breastfeeding women to become vaccinated. Through a cross-sectional online study conducted after the first pandemic wave, vaccination practices and willingness to become vaccinated against SARS-CoV-2 if a vaccine was available were evaluated through binary, multi-choice, and open-ended questions. Factors associated with vaccine willingness were evaluated through univariable and multivariable analysis. A total of 1551 women responded to questions related to the primary outcome. Only 29.7% (153/515) of pregnant and 38.6% (400/1036) of breastfeeding women were willing to get vaccinated against SARS-CoV-2 if a vaccine had been available during the first wave. Positive predictors associated with SARS-CoV-2 vaccine acceptance were an age older than 40 years, a higher educational level, history of influenza vaccination within the previous year, having an obstetrician as the primary healthcare practitioner, and being in their third trimester of pregnancy. After the first pandemic wave, Switzerland had a low SARS-CoV-2 vaccination acceptance rate, emphasizing the need to identify and reduce barriers for immunization in pregnant and breastfeeding women, particularly among the youngest and those with a lower educational level. View Full-Text
Keywords: SARS-CoV-2; coronavirus; COVID-19; pregnancy; breastfeeding; vaccine willingness SARS-CoV-2; coronavirus; COVID-19; pregnancy; breastfeeding; vaccine willingness
Show Figures

Figure 1

MDPI and ACS Style

Stuckelberger, S.; Favre, G.; Ceulemans, M.; Nordeng, H.; Gerbier, E.; Lambelet, V.; Stojanov, M.; Winterfeld, U.; Baud, D.; Panchaud, A.; Pomar, L. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199. https://doi.org/10.3390/v13071199

AMA Style

Stuckelberger S, Favre G, Ceulemans M, Nordeng H, Gerbier E, Lambelet V, Stojanov M, Winterfeld U, Baud D, Panchaud A, Pomar L. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses. 2021; 13(7):1199. https://doi.org/10.3390/v13071199

Chicago/Turabian Style

Stuckelberger, Sarah, Guillaume Favre, Michael Ceulemans, Hedvig Nordeng, Eva Gerbier, Valentine Lambelet, Milos Stojanov, Ursula Winterfeld, David Baud, Alice Panchaud, and Léo Pomar. 2021. "SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland" Viruses 13, no. 7: 1199. https://doi.org/10.3390/v13071199

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop